Generate Biomedicines Inc (GENB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -128,969 | -61,714 | -222,965 | -101,056 | -44,314 |
| Depreciation Amortization | 5,964 | 3,127 | 10,395 | 5,022 | 2,495 |
| Accounts receivable | N/A | N/A | N/A | -32 | -91 |
| Accounts payable and accrued liabilities | 1,800 | 3,754 | N/A | -151 | -597 |
| Other Working Capital | -35,109 | -30,653 | -14,616 | -18,804 | -17,440 |
| Other Operating Activity | 17,982 | 5,098 | 26,567 | 13,092 | 6,771 |
| Operating Cash Flow | $-138,332 | $-80,388 | $-200,619 | $-101,929 | $-53,176 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,714 | 61,219 | -3,514 | -905 | 152,882 |
| Purchase Of Investment | -321,759 | -321,153 | N/A | -142,508 | -77,350 |
| Sale Of Investment | 99,850 | N/A | N/A | 201,877 | N/A |
| Other Investing Activity | 0 | 0 | 120,281 | 0 | 0 |
| Investing Cash Flow | $-226,623 | $-259,934 | $116,767 | $58,464 | $75,532 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,108 | -1,115 | N/A | -5,062 | -2,646 |
| Common Stock Issued | 372,920 | 372,506 | N/A | 22,609 | 22,456 |
| Other Financing Activity | 7,500 | 7,500 | 28,059 | 2,750 | 750 |
| Financing Cash Flow | $378,312 | $378,891 | $28,059 | $20,297 | $20,560 |
| Beginning Cash Position | 126,036 | 126,038 | 181,831 | 181,831 | 181,831 |
| End Cash Position | 139,393 | 164,607 | 126,038 | 158,663 | 224,747 |
| Net Cash Flow | $13,357 | $38,569 | $-55,793 | $-23,168 | $42,916 |
| Free Cash Flow | |||||
| Operating Cash Flow | -138,332 | -80,388 | -200,619 | -101,929 | -53,176 |
| Capital Expenditure | -4,714 | -3,781 | N/A | -905 | -751 |
| Free Cash Flow | -143,046 | -84,169 | -200,619 | -102,834 | -53,927 |